AI assistant
Microbot Medical Inc. — Director's Dealing 2015
Jan 29, 2015
33819_dirs_2015-01-28_37ad55b5-0f5e-4873-b356-6ddf9d964f67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2015-01-27
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-27 | Common Stock | F | 20995 | $1.07 | Disposed | 706511 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3643 | Indirect |
| Common Stock | 26369 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by her from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 210,000 restricted stock units, with 70,000 of these vesting on each of June 6, 2015, June 6, 2026, and June 6, 2017; (2) 250,000 restricted stock units, with 83,333 of these vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018; and (3) 100,000 restricted stock units with performance based vesting.
F3: 2,284 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.